Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study.
Sibila O, Stobo J, Perea L, Gao YH, Xu JF, Lind H, Viligorska K, Spinou A, Polverino E, Ringshausen FC, Vendrell M, Burgel PR, Haworth CS, Loebinger MR, Lorent N, Dhar R, Choi H, Chotirmall SH, De Soyza A, Hurst JR, Brown JS, van der Eerden M, Kauppi P, Johnson ED, Mendez R, Dimakou K, Bossios A, Torres A, Blasi F, Shteinberg M, Elborn SJ, Goeminne PC, Aliberti S, Jayaram L, Karalus N, Taylor SL, Martin ML, Burr LD, Wong C, Terpstra L, Altenburg J, Boersma W, Chalmers JD.
Sibila O, et al. Among authors: terpstra l.
Lancet Respir Med. 2025 Oct;13(10):911-920. doi: 10.1016/S2213-2600(25)00160-2. Epub 2025 Aug 27.
Lancet Respir Med. 2025.
PMID: 40885209
Free article.